BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Dr. Alfred Hackenberger Elected To The Supervisory Board Of Axaron Bioscience AG


10/19/2005 5:10:58 PM

Heidelberg, Germany, April 25th, 2005 - Since March 2005, Dr. Alfred Hackenberger, President of the Competence Center Specialty Chemicals Research at BASF AG, has been appointed to the Supervisory Board of Axaron Bioscience AG. As agreed, he is succeeding Prof. Dr. Hans-Jürgen Quadbeck-Seeger, lastly a member of the Executive Board of BASF AG. Dr. Hackenberger has been with BASF since 1981. As a PhD in chemistry, he started his career with the Chemical Group in the Colourants laboratory. In the following years he gained experience as Sales Manager ED (Dispersions) and head of the Chemicals Division of BASF AG in Brazil. In 1996 he became head of the sub-department responsible for marketing carboxyl and colourant intermediates. Two years later, Dr. Hackenberger was appointed head of Research Fine Chemicals, and in 2001 he became Group Vice President of the Regional Business Unit Fine Chemicals Asia-Pacific based in Hong Kong. Since 2004 Dr. Hackenberger has been President of the Competence Center Specialty Chemicals Research. Furthermore Chairman Friedrich Christ, Senior Vice President of BASF AG, and Prof. Michael Kramer, General Manager of Lynx GmbH, are still associated with the Supervisory Board of Axaron Bioscience AG.

Illustration material is available on request. Please call +49 (0)89/ 41 95 99-88 or e-mail: axaron@maisberger.com

Media Contact: Dr. Alexander Pschera Axaron Bioscience AG Im Neuenheimer Feld 515 D-69120 Heidelberg Tel.: +49 (0)6221 454-705 Fax: +49 (0)6221 454-776 alexander.pschera@axaron.com www.axaron.com

Axaron Bioscience AG pioneers innovative therapies for neurodegenerative diseases such as stroke or Parkinson's. In addition to an attractive product portfolio, the biotechnology company capitalizes on its integrated functional genomics and proteomics technology platform and its world-leading network of expert partners in the CNS field. Axaron currently employs a staff of 35 at its headquarters in Heidelberg. For further information please visit www.axaron.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES